PERROTTA, Fabio Massimo
PERROTTA, Fabio Massimo
DIPARTIMENTO DI MEDICINA E DI SCIENZE DELLA SALUTE
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings
2019-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; De Socio, Antonia; Lubrano, Ennio
An overview of low disease activity and remission in psoriatic arthritis.
2015-01-01 LUBRANO DI SCORPANIELLO, Ennio; Perrotta, Fm; Kavanaugh, A.
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment
2016-01-01 Perrotta, Fabio Massimo; Astorri, Davide; Zappia, Marcello; Reginelli, Alfonso; Brunese, Luca; LUBRANO DI SCORPANIELLO, Ennio
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting
2019-01-01 Lubrano, Ennio; Scriffignano, Silvia; De Socio, Antonia; Perrotta, Fabio Massimo
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study
2019-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; Lubrano, Ennio
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors
2016-01-01 LUBRANO DI SCORPANIELLO, Ennio; Parsons, Wendy J.; Perrotta, Fabio Massimo
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients
2017-01-01 Perrotta, Fabio Massimo; Ceccarelli, Fulvia; Barbati, Cristiana; Colasanti, Tania; Montepaone, Monica; Alessandri, Cristiano; Valesini, Guido; LUBRANO DI SCORPANIELLO, Ennio
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices
2013-01-01 Perrotta, F. M.; Scarno, A.; Carboni, A.; Bernardo, V.; Montepaone, M.; LUBRANO DI SCORPANIELLO, Ennio; Spadaro, A.
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices
2020-01-01 Lubrano, E.; Scriffignano, S.; Azuaga, A. B.; Ramirez, J.; Canete, J.; Perrotta, F. M.
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study
2021-01-01 Lubrano, Ennio; Scriffignano, Silvia; Morelli, Romeo; Perrotta, Fabio Massimo
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis
2014-01-01 Scarno, A; Perrotta, Fm; Cardini, F; Carboni, A; Annibali, G; LUBRANO DI SCORPANIELLO, Ennio; Spadaro, A.
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis
2016-01-01 LUBRANO DI SCORPANIELLO, Ennio; Perrotta, Fabio Massimo
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations
2023-01-01 Scriffignano, Silvia; Lories, Rik; Nzeusseu Toukap, Adrien; Lubrano, Ennio; Ciccia, Francesco; Steinfeld, Serge; Perrotta, Fabio Massimo; Pantano, Ilenia; Van den Bosch, Filip; de Vlam, Kurt
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment
2020-01-01 Navarini, Luca; Caso, Francesco; Costa, Luisa; Currado, Damiano; Stola, Liliana; Perrotta, Fabio; Delfino, Lorenzo; Sperti, Michela; Deriu, Marco A; Ruscitti, Piero; Pavlych, Viktoriya; Corrado, Addolorata; Di Benedetto, Giacomo; Tasso, Marco; Ciccozzi, Massimo; Laudisio, Alice; Lunardi, Claudio; Cantatore, Francesco Paolo; Lubrano, Ennio; Giacomelli, Roberto; Scarpa, Raffaele; Afeltra, Antonella
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab
2020-01-01 Perrotta, F. M.; Scriffignano, S.; Fatica, M.; Specchia, M.; Lubrano, E.
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report
2017-01-01 Perrotta, Fabio Massimo; Fici, Michelangelo; Guerra, Germano; Brunese, Luca; Salvarani, Carlo; LUBRANO DI SCORPANIELLO, Ennio
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis
2012-01-01 Perrotta, F; Spadaro, A; Carboni, A; Scarno, A.
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis
2011-01-01 Spadaro, A; Iagnocco, A; Perrotta, F; Modesti, M; Scarno, A; Valesini, G.
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
2022-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; Ciccia, Francesco; Lubrano, Ennio
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort
2017-01-01 LUBRANO DI SCORPANIELLO, Ennio; DE SOCIO, Antonia; Perrotta, Fabio Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings | 1-gen-2019 | Perrotta, Fabio Massimo; Scriffignano, Silvia; De Socio, Antonia; Lubrano, Ennio | |
| An overview of low disease activity and remission in psoriatic arthritis. | 1-gen-2015 | LUBRANO DI SCORPANIELLO, Ennio; Perrotta, Fm; Kavanaugh, A. | |
| An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment | 1-gen-2016 | Perrotta, Fabio Massimo; Astorri, Davide; Zappia, Marcello; Reginelli, Alfonso; Brunese, Luca; LUBRANO DI SCORPANIELLO, Ennio | |
| Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting | 1-gen-2019 | Lubrano, Ennio; Scriffignano, Silvia; De Socio, Antonia; Perrotta, Fabio Massimo | |
| Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study | 1-gen-2019 | Perrotta, Fabio Massimo; Scriffignano, Silvia; Lubrano, Ennio | |
| Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors | 1-gen-2016 | LUBRANO DI SCORPANIELLO, Ennio; Parsons, Wendy J.; Perrotta, Fabio Massimo | |
| Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients | 1-gen-2017 | Perrotta, Fabio Massimo; Ceccarelli, Fulvia; Barbati, Cristiana; Colasanti, Tania; Montepaone, Monica; Alessandri, Cristiano; Valesini, Guido; LUBRANO DI SCORPANIELLO, Ennio | |
| Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices | 1-gen-2013 | Perrotta, F. M.; Scarno, A.; Carboni, A.; Bernardo, V.; Montepaone, M.; LUBRANO DI SCORPANIELLO, Ennio; Spadaro, A. | |
| Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices | 1-gen-2020 | Lubrano, E.; Scriffignano, S.; Azuaga, A. B.; Ramirez, J.; Canete, J.; Perrotta, F. M. | |
| Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study | 1-gen-2021 | Lubrano, Ennio; Scriffignano, Silvia; Morelli, Romeo; Perrotta, Fabio Massimo | |
| Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis | 1-gen-2014 | Scarno, A; Perrotta, Fm; Cardini, F; Carboni, A; Annibali, G; LUBRANO DI SCORPANIELLO, Ennio; Spadaro, A. | |
| Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis | 1-gen-2016 | LUBRANO DI SCORPANIELLO, Ennio; Perrotta, Fabio Massimo | |
| Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations | 1-gen-2023 | Scriffignano, Silvia; Lories, Rik; Nzeusseu Toukap, Adrien; Lubrano, Ennio; Ciccia, Francesco; Steinfeld, Serge; Perrotta, Fabio Massimo; Pantano, Ilenia; Van den Bosch, Filip; de Vlam, Kurt | |
| Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment | 1-gen-2020 | Navarini, Luca; Caso, Francesco; Costa, Luisa; Currado, Damiano; Stola, Liliana; Perrotta, Fabio; Delfino, Lorenzo; Sperti, Michela; Deriu, Marco A; Ruscitti, Piero; Pavlych, Viktoriya; Corrado, Addolorata; Di Benedetto, Giacomo; Tasso, Marco; Ciccozzi, Massimo; Laudisio, Alice; Lunardi, Claudio; Cantatore, Francesco Paolo; Lubrano, Ennio; Giacomelli, Roberto; Scarpa, Raffaele; Afeltra, Antonella | |
| Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab | 1-gen-2020 | Perrotta, F. M.; Scriffignano, S.; Fatica, M.; Specchia, M.; Lubrano, E. | |
| Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report | 1-gen-2017 | Perrotta, Fabio Massimo; Fici, Michelangelo; Guerra, Germano; Brunese, Luca; Salvarani, Carlo; LUBRANO DI SCORPANIELLO, Ennio | |
| Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis | 1-gen-2012 | Perrotta, F; Spadaro, A; Carboni, A; Scarno, A. | |
| Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis | 1-gen-2011 | Spadaro, A; Iagnocco, A; Perrotta, F; Modesti, M; Scarno, A; Valesini, G. | |
| Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort | 1-gen-2022 | Perrotta, Fabio Massimo; Scriffignano, Silvia; Ciccia, Francesco; Lubrano, Ennio | |
| Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort | 1-gen-2017 | LUBRANO DI SCORPANIELLO, Ennio; DE SOCIO, Antonia; Perrotta, Fabio Massimo |